Brain perfusion and cognitive function changes in hypertensive patients

Irina Yu Efimova, Nataliya Yurievna Efimova, Sergey V. Triss, Yuri B. Lishmanov

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The aim of our study was to estimate brain perfusion and cognitive function (CF) in patients with arterial hypertension (AH) before and after hypotensive therapy. The study included 15 patients (mean age, 53.0±5.7 years) with previously untreated or ineffectively treated essential hypertension of the second degree. All patients underwent brain single photon emission computed tomography (SPECT) scanning with 99mTc-hexamethylpropylene amine oxime (99mTc-HMPAO) and comprehensive neuropsychological testing before and after 24 weeks of hypotensive therapy (anglotensin-converting enzyme [ACE] inhibitor or diuretics). The brain perfusion was significantly lower (15-22%) in all regions of AH patients. These patients showed a 25% decrease in attention and psychomotor speed as well as a 14% decrease in mentation. Six months of hypotensive therapy led to an increase in brain perfusion by an average of 7-11% in all brain regions. After treatment these patients demonstrated an average 11-18% improvements in attention and psychomotor speed, as well as an average 10% improvement in abstract mentation. Marked signs of brain hypoperfusion and impaired CF: decrease in attention, slowing psychomotor speed and mentation was found in hypertensive patients even without focal neurological symptomatology. Twenty-four weeks of hypotensive treatment with ACE inhibitors or diuretics had a positive effect on cerebral perfusion and led to CF improvement.

Original languageEnglish
Pages (from-to)673-678
Number of pages6
JournalHypertension Research
Volume31
Issue number4
DOIs
Publication statusPublished - Apr 2008

Fingerprint

Cognition
Perfusion
Brain
Enzyme Inhibitors
Diuretics
Hypertension
Therapeutics
Oximes
Single-Photon Emission-Computed Tomography
Amines

Keywords

  • Brain perfusion
  • Cognitive function
  • Hypertension
  • Hypotensive therapy
  • Single photon emission computed tomography

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Brain perfusion and cognitive function changes in hypertensive patients. / Efimova, Irina Yu; Efimova, Nataliya Yurievna; Triss, Sergey V.; Lishmanov, Yuri B.

In: Hypertension Research, Vol. 31, No. 4, 04.2008, p. 673-678.

Research output: Contribution to journalArticle

Efimova, Irina Yu ; Efimova, Nataliya Yurievna ; Triss, Sergey V. ; Lishmanov, Yuri B. / Brain perfusion and cognitive function changes in hypertensive patients. In: Hypertension Research. 2008 ; Vol. 31, No. 4. pp. 673-678.
@article{414aa16c13914e6b81aa77a2b7b0d1c2,
title = "Brain perfusion and cognitive function changes in hypertensive patients",
abstract = "The aim of our study was to estimate brain perfusion and cognitive function (CF) in patients with arterial hypertension (AH) before and after hypotensive therapy. The study included 15 patients (mean age, 53.0±5.7 years) with previously untreated or ineffectively treated essential hypertension of the second degree. All patients underwent brain single photon emission computed tomography (SPECT) scanning with 99mTc-hexamethylpropylene amine oxime (99mTc-HMPAO) and comprehensive neuropsychological testing before and after 24 weeks of hypotensive therapy (anglotensin-converting enzyme [ACE] inhibitor or diuretics). The brain perfusion was significantly lower (15-22{\%}) in all regions of AH patients. These patients showed a 25{\%} decrease in attention and psychomotor speed as well as a 14{\%} decrease in mentation. Six months of hypotensive therapy led to an increase in brain perfusion by an average of 7-11{\%} in all brain regions. After treatment these patients demonstrated an average 11-18{\%} improvements in attention and psychomotor speed, as well as an average 10{\%} improvement in abstract mentation. Marked signs of brain hypoperfusion and impaired CF: decrease in attention, slowing psychomotor speed and mentation was found in hypertensive patients even without focal neurological symptomatology. Twenty-four weeks of hypotensive treatment with ACE inhibitors or diuretics had a positive effect on cerebral perfusion and led to CF improvement.",
keywords = "Brain perfusion, Cognitive function, Hypertension, Hypotensive therapy, Single photon emission computed tomography",
author = "Efimova, {Irina Yu} and Nataliya Yurievna Efimova and Triss, {Sergey V.} and Lishmanov, {Yuri B.}",
year = "2008",
month = "4",
doi = "10.1291/hypres.31.673",
language = "English",
volume = "31",
pages = "673--678",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Brain perfusion and cognitive function changes in hypertensive patients

AU - Efimova, Irina Yu

AU - Efimova, Nataliya Yurievna

AU - Triss, Sergey V.

AU - Lishmanov, Yuri B.

PY - 2008/4

Y1 - 2008/4

N2 - The aim of our study was to estimate brain perfusion and cognitive function (CF) in patients with arterial hypertension (AH) before and after hypotensive therapy. The study included 15 patients (mean age, 53.0±5.7 years) with previously untreated or ineffectively treated essential hypertension of the second degree. All patients underwent brain single photon emission computed tomography (SPECT) scanning with 99mTc-hexamethylpropylene amine oxime (99mTc-HMPAO) and comprehensive neuropsychological testing before and after 24 weeks of hypotensive therapy (anglotensin-converting enzyme [ACE] inhibitor or diuretics). The brain perfusion was significantly lower (15-22%) in all regions of AH patients. These patients showed a 25% decrease in attention and psychomotor speed as well as a 14% decrease in mentation. Six months of hypotensive therapy led to an increase in brain perfusion by an average of 7-11% in all brain regions. After treatment these patients demonstrated an average 11-18% improvements in attention and psychomotor speed, as well as an average 10% improvement in abstract mentation. Marked signs of brain hypoperfusion and impaired CF: decrease in attention, slowing psychomotor speed and mentation was found in hypertensive patients even without focal neurological symptomatology. Twenty-four weeks of hypotensive treatment with ACE inhibitors or diuretics had a positive effect on cerebral perfusion and led to CF improvement.

AB - The aim of our study was to estimate brain perfusion and cognitive function (CF) in patients with arterial hypertension (AH) before and after hypotensive therapy. The study included 15 patients (mean age, 53.0±5.7 years) with previously untreated or ineffectively treated essential hypertension of the second degree. All patients underwent brain single photon emission computed tomography (SPECT) scanning with 99mTc-hexamethylpropylene amine oxime (99mTc-HMPAO) and comprehensive neuropsychological testing before and after 24 weeks of hypotensive therapy (anglotensin-converting enzyme [ACE] inhibitor or diuretics). The brain perfusion was significantly lower (15-22%) in all regions of AH patients. These patients showed a 25% decrease in attention and psychomotor speed as well as a 14% decrease in mentation. Six months of hypotensive therapy led to an increase in brain perfusion by an average of 7-11% in all brain regions. After treatment these patients demonstrated an average 11-18% improvements in attention and psychomotor speed, as well as an average 10% improvement in abstract mentation. Marked signs of brain hypoperfusion and impaired CF: decrease in attention, slowing psychomotor speed and mentation was found in hypertensive patients even without focal neurological symptomatology. Twenty-four weeks of hypotensive treatment with ACE inhibitors or diuretics had a positive effect on cerebral perfusion and led to CF improvement.

KW - Brain perfusion

KW - Cognitive function

KW - Hypertension

KW - Hypotensive therapy

KW - Single photon emission computed tomography

UR - http://www.scopus.com/inward/record.url?scp=44649104381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44649104381&partnerID=8YFLogxK

U2 - 10.1291/hypres.31.673

DO - 10.1291/hypres.31.673

M3 - Article

VL - 31

SP - 673

EP - 678

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 4

ER -